Advanced search
Publication Cover
Open Access Emergency Medicine Volume 16, 2024 - Issue
Submit an article Journal homepage
91
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A Case of Severe Rhabdomyolysis, Acute Myocardial Damage and Multi-Organ Dysfunction Syndrome in a Patient with Novel Coronavirus Pneumonia

Shuaishuai YuanDivision of Cardiovascular Intensive Care (C-ICU), Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Guangdong, People’s Republic of ChinaView further author information
,
Yuting HuangDivision of Cardiovascular Intensive Care (C-ICU), Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Guangdong, People’s Republic of ChinaView further author information
,
Pailing XieDivision of Cardiovascular Intensive Care (C-ICU), Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Guangdong, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Peijun LiDivision of Cardiovascular Intensive Care (C-ICU), Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Guangdong, People’s Republic of ChinaORCID Iconhttps://orcid.org/0009-0008-2313-4657View further author information
ORCID Icon
Pages 19-28 | Received 04 Nov 2023, Accepted 24 Jan 2024, Published online: 31 Jan 2024

References

  • Gavriatopoulou M, Korompoki E, Fotiou D, et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;20(4):493–506. doi:10.1007/s10238-020-00648-x
  • Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol. 2020;45(8):100618. doi:10.1016/j.cpcardiol.2020.100618
  • Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015;15(1):58–69.
  • Ali L, Mohammed I, Janjua I, et al. Acute Myocardial Injury and Rhabdomyolysis in COVID-19 Patients: incidence and Mortality. Cureus. 2021;13(10):1.
  • Del Prete A, Conway F, Della Rocca DG, et al. COVID-19, acute myocardial injury, and infarction. Card Electrophysiol Clin. 2022;14(1):29–39. doi:10.1016/j.ccep.2021.10.004
  • Zhao W, Li H, Li J, Xu B, Xu J. The mechanism of multiple organ dysfunction syndrome in patients with COVID-19. Med Virol. 2022;94(5):1886–1892. doi:10.1002/jmv.27627
  • Stahl K, Rastelli E, Schoser B. A systematic review on the definition of rhabdomyolysis. J Neurol. 2020;267(4):877–882. doi:10.1007/s00415-019-09185-4
  • Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis -- an overview for clinicians. Crit Care. 2005;9(2):158–169. doi:10.1186/cc2978
  • Haroun MW, Dieiev V, Kang J, et al. Rhabdomyolysis in COVID-19 patients: a retrospective observational study. Cureus. 2021;13(1):e12552. doi:10.7759/cureus.12552
  • Sandoval Y, Jl J Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19. J Am Coll Cardiol. 2020;76(10):1244–1258. doi:10.1016/j.jacc.2020.06.068
  • Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810. doi:10.1001/jamacardio.2020.0950
  • Russak AJ, Paranjpe I, Richter F, et al. Mount sinai COVID informatics center. prevalence and impact of myocardial injury in patients hospitalized with COVID-19 Infection. J Am Coll Cardiol. 2020;76(5):533–546. doi:10.1016/j.jacc.2020.06.007
  • Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J. Gen Intern Med. 2020;35(5):1545–1549. doi:10.1007/s11606-020-05762-w
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
  • Borku Uysal B, Ikitimur H, Yavuzer S, Islamoglu MS, Cengiz M. Case report: a COVID-19 patient presenting with mild rhabdomyolysis. Am J Trop Med Hyg. 2020;103(2):847–850. doi:10.4269/ajtmh.20-0583
  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7
  • Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry Depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052
  • Zhang D, Zhang X, Ma R, et al. Ultra-fast and onsite interrogation Of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in waters via surface enhanced raman scattering (SERS). Water Res. 2021;200:117243. doi:10.1016/j.watres.2021.117243
  • Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. doi:10.1002/path.1570
  • Fox SE, Lameira FS, Rinker EB, Vander Heide RS. Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19. Ann Intern Med. 2020;173(12):1025–1027. doi:10.7326/L20-0882
  • Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41(32):3038–3044. doi:10.1093/eurheartj/ehaa623
  • Fadila MF, Wool KJ. Rhabdomyolysis secondary to influenza a infection: a case report and review of the literature. N Am J Med Sci. 2015;7(3):122–124. doi:10.4103/1947-2714.153926
  • Chen R, Lan Z, Ye J, et al. Cytokine Storm: the Primary determinant for the pathophysiological evolution of covid-19 deterioration. Front Immunol. 2021;12:589095. doi:10.3389/fimmu.2021.589095

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.